Minnesota2026Passed Legislature
HF3609
Continuing Rules for Drug Manufacturers and 340B Drugs
Last scannedAug 22, 2026, 3:39 AM
In one sentence
This law keeps the rule that drug makers cannot stop delivering certain discounted drugs to eligible groups in Minnesota, adds a way to punish violations by calling them unfair trade practices, and removes the date when this rule would have ended.
What it does
- Continues the ban on drug manufacturers restricting delivery of 340B prescription drugs.
- Removes the expiration date that was set for July 1, 2027.
- Defines breaking these rules as an unfair or deceptive trade practice under section 8.31.
- Allows the attorney general to enforce this law against violators.
Who it affects
- Drug manufacturers
- The Minnesota Attorney General
Limits and unknowns
- The text does not list specific penalties for breaking this rule.
- The effective date of when these changes start is not listed in the provided information.
Plain language
Terms to know
- 340B prescription drugs
- Medicines covered under the section of law regarding access to discounted drugs.
- Unfair or deceptive trade practice
- A business action that breaks the law by misleading people or acting unfairly in commerce, as defined in section 8.31.
Official record
Sources
Official summary
Disallowance of drug manufacturers from restricting delivery of 340B prescription drugs continued, enforcement provided, and expiration date removed.
Official activity
Bill history
- See Senate file in House SF3769House
- Author added RepinskiHouse
- Author added BakerHouse
- Author stricken SchomackerHouse
- Motion to recall and re-refer, motion did not prevail Commerce Finance and PolicyHouse
- Author added KeelerHouse
- Author added Anderson, P. H.House
- Author stricken PerrymanHouse
- Author added GanderHouse
- Author added RehrauerHouse
- Authors added Norris, Johnson, P., and SwedzinskiHouse
- Author stricken GillmanHouse
- Introduction and first reading, referred to Health Finance and PolicyHouse